Michel, Lars
Totzeck, Matthias
Rassaf, Tienush
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
First Online: 20 October 2021
Declarations
:
: Matthias Totzeck and Tienush Rassaf report personal fees and other from Edwards, Novartis, personal fees and other from Bristol Myers Squibb, personal fees and other from Bayer, personal fees and other from Daiichi Sankyo, personal fees and other from AstraZeneca, outside the submitted work. Lars Michel declares that there is no conflict of interest.